These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Telomerase activity in uveal melanomas]. Rohrbach JM; Riedinger C; Wild M; Partsch M Ophthalmologe; 2000 May; 97(5):359-63. PubMed ID: 10892281 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization. Heine B; Hummel M; Demel G; Stein H J Pathol; 1998 Jun; 185(2):139-44. PubMed ID: 9713339 [TBL] [Abstract][Full Text] [Related]
4. Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: comparison with hTR expression. Ferlicot S; Paradis V; Dargère D; Monges G; Bedossa P J Clin Pathol; 1999 Oct; 52(10):725-9. PubMed ID: 10674027 [TBL] [Abstract][Full Text] [Related]
5. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue. Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577 [TBL] [Abstract][Full Text] [Related]
6. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions. Hiyama T; Yokozaki H; Kitadai Y; Tahara E; Tahara H; Ide T; Haruma K; Yasui W; Kajiyama G; Tahara E Jpn J Cancer Res; 1998 Nov; 89(11):1187-94. PubMed ID: 9914788 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions. Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM; Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205 [TBL] [Abstract][Full Text] [Related]
8. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731 [TBL] [Abstract][Full Text] [Related]
9. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Soder AI; Hoare SF; Muir S; Going JJ; Parkinson EK; Keith WN Oncogene; 1997 Mar; 14(9):1013-21. PubMed ID: 9070649 [TBL] [Abstract][Full Text] [Related]
10. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215 [TBL] [Abstract][Full Text] [Related]
11. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785 [TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. Yashima K; Piatyszek MA; Saboorian HM; Virmani AK; Brown D; Shay JW; Gazdar AF J Clin Pathol; 1997 Feb; 50(2):110-7. PubMed ID: 9155690 [TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Burger AM; Bibby MC; Double JA Br J Cancer; 1997; 75(4):516-22. PubMed ID: 9052403 [TBL] [Abstract][Full Text] [Related]
14. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010 [TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in prognostic histopathologic features of melanoma. Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589 [TBL] [Abstract][Full Text] [Related]
16. Telomerase expression in sebaceous carcinoma of the eyelid. Li B; Li ND; Xu XL; Zheng BH; Sun XL; Li LQ; Chen CX Chin Med J (Engl); 2004 Mar; 117(3):445-8. PubMed ID: 15043789 [TBL] [Abstract][Full Text] [Related]
17. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877 [TBL] [Abstract][Full Text] [Related]
18. [Expression of telomerase and its RNA in nasopharyngeal carcinoma]. Wen Z; Xiao J; Tang F; Tian Y; Zhao S; Chen B Chin Med J (Engl); 2000 Jun; 113(6):525-8. PubMed ID: 11775871 [TBL] [Abstract][Full Text] [Related]
19. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570 [TBL] [Abstract][Full Text] [Related]
20. Expression and distribution of MMPs and TIMPs in human uveal melanoma. Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]